Latest News & Updates
Breaking News
12 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Moleculin Biotech Secures Hong Kong Patent for Liposomal Annamycin Ahead of Phase 3 Data
Moleculin Biotech adds Hong Kong to its Annamycin IP portfolio ahead of imminent Phase 3 data, extending formulation exclusivity through 2040.
Pharma Now Editorial Team
FDA Issues Final Guidance on Postapproval Pregnancy Safety Studies for Drugs and Biologics
FDA's final guidance on postapproval pregnancy safety studies sets a methodological framework covering registries, real-world data, and case-based descriptive studies.
Pharma Now Editorial Team
FDA Finalizes Pulmonary TB Drug Development Guidance for Antibacterial Sponsors in 2026
FDA finalizes pulmonary TB drug development guidance under docket FDA-2013-D-1319, setting clinical trial expectations for antibacterial sponsors.
Pharma Now Editorial Team
FDA Finalizes CDI Drug Development Guidance Covering Treatment, Recurrence Reduction, and Prevention Pathways
FDA finalizes CDI drug development guidance under docket FDA-2022-D-1261, covering treatment, recurrence reduction, and prevention indication pathways.
Pharma Now Editorial Team
